These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 239322)
1. New drugs and new treatments. Walker E Mod Healthc (Short Term Care); 1975 Jul; 4(1):70B,70D. PubMed ID: 239322 [No Abstract] [Full Text] [Related]
2. Halcinonide (Halog)--another new topical steroid. Med Lett Drugs Ther; 1975 May; 17(11):46-7. PubMed ID: 1128441 [No Abstract] [Full Text] [Related]
3. Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs. Bagatell FK; Augustine MA Curr Ther Res Clin Exp; 1974 Jul; 16(7):748-57. PubMed ID: 4210465 [No Abstract] [Full Text] [Related]
4. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment. Clark RF; Clement ER Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960 [TBL] [Abstract][Full Text] [Related]
5. Procedures for the clinical investigation of a topical corticosteroid. Craps L; Ferner U Acta Derm Venereol Suppl (Stockh); 1973; 53():13-23. PubMed ID: 4585161 [No Abstract] [Full Text] [Related]
6. Halcinonide in the treatment of corticosteroid responsive dermatoses. Leibsohn E; Bagatell FK Br J Dermatol; 1974 Apr; 90(4):435-40. PubMed ID: 4596068 [No Abstract] [Full Text] [Related]
7. [Side effects of topical corticosteroid therapy]. Kero M; Hannuksela M Duodecim; 1977; 93(20):1257-64. PubMed ID: 145363 [No Abstract] [Full Text] [Related]
12. [Therapeutic trial of a new topical anti-inflammatory agent]. Jezequel J; Becuwe B; Daniel C; Geraudel O J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1979 Jan; 28(1):65-6, 68. PubMed ID: 155139 [No Abstract] [Full Text] [Related]
13. [Diagnosis and therapy of bromoderma tuberosum]. Schmoeckel C Hautarzt; 1976 Aug; 27(8):396-8. PubMed ID: 134008 [TBL] [Abstract][Full Text] [Related]
14. Letter: Adrenal unresponsiveness associated with clobetasol propionate. Feiwel M; Kelly WF Lancet; 1974 Jul; 2(7872):112-3. PubMed ID: 4136855 [No Abstract] [Full Text] [Related]
15. Topical Corticosteroids International Symposium, Venice, May 1972. Introductory remarks. Craps L Acta Derm Venereol Suppl (Stockh); 1973; 53():9-11. PubMed ID: 4585162 [No Abstract] [Full Text] [Related]
16. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products. Worthington HE Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660 [No Abstract] [Full Text] [Related]
17. Microbiological evaluation of the efficacy of anti-infective drugs. Dye WE Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):495-7. PubMed ID: 4887949 [No Abstract] [Full Text] [Related]
18. Evaluation of topical anti-inflammatory steroid formulations in an Arthus model of inflammation. Goldlust MB; Palmer DM; Augustine MA J Invest Dermatol; 1976 Mar; 66(3):157-60. PubMed ID: 129493 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of Décoderme cream]. Huriez C; Croquette A Lille Med; 1974 Apr; 19(4 Suppl 11):517-20. PubMed ID: 4612279 [No Abstract] [Full Text] [Related]
20. The new steroids: clinical experience in ulcerative colitis. Jewell DP Mt Sinai J Med; 1990 Oct; 57(5):293-6. PubMed ID: 1710774 [No Abstract] [Full Text] [Related] [Next] [New Search]